Want to track BRRGF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Oncoinvent ASA (BRRGF) Statistics
Valuation metrics
Market Cap 9.49B
Enterprise value 264.92M
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) 21.75
Price/Book (mrq) 13.03
Enterprise Value/Revenue 11.5
Enterprise Value/EBITDA -2.17
Overview
Shares outstanding 4.48M
Float 656.37K
Shares short -
% Held by insiders 0.27%
% Held by institutions 0.39%
Average volume (10 days) 3.73K
Average volume (90 days) 1.24K
Price summary
52-Week low 0.03
52-Week high 97.09
Beta -
50-Day moving average 97.09
200-Day moving average 97.09
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:100
Last split Date 20 Jan 2026
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2024
Profitability
Profit margin -
Operating margin -4.35%
Operational effectiveness
Return on assets -0.76%
Return on equity -1.06%
Income Statement
Revenue (ttm) 2.16M
Revenue per share (ttm) 15.68
Quarterly revenue growth (yoy) 177.51%
Gross profit (ttm) 2.16M
EBITDA -10.67M
Net income to common (ttm) -11.52M
Diluted EPS (ttm) -204.13
Quarterly earnings growth (yoy) 0.92%
Balance Sheet
Total cash (mrq) 8.13M
Total cash per share (mrq) 77.12
Total debt (mrq) 670.55K
Total Debt/Equity (mrq) 8.95
Current ratio (mrq) 2.61%
Book value per share (mrq) 7.45
Cash Flow
Cash flow statement -9.04M
Levered free cash flow (LFCF) -155.07M
